CTOs on the Move


 
Foria is an innovative health & sexual wellness company, rooted in the proven wisdom of plants and powered by compassion. Our all natural Cannabis & Hemp formulas have been changing lives since 2014. As the first brand to create comprehensive product lines for intimacy, relief, and optimal wellbeing for women and people with vulvas, it is our joy and mission to offer effective products for important and under-served life experiences. With an unwavering commitment to clean ingredients, organic & regenerative farming, sex education, and responsible packaging, we maintain the highest standards of purity and transparency — for your health, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

TeleMed Systems

TeleMed Systems is a Hudson, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southeast Alabama Medical Center

Southeast Alabama Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Southeast Alabama Medical Center is based in Dothan, AL. You can find more information on Southeast Alabama Medical Center at www.samc.org

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

Harborview Health Care

Harborview Health Care is a Morehead City, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VirtuOx

VirtuOx is the worlds largest provider of Respiratory, Sleep and Insomnia Testing in the privacy and comfort of your home!